u/Travelclone

AI places an sp valuation post one indiacation approval at $4 per share assuming a $500m revenue stream and a $100+ Billion valuation for a $30B revenue stream.. So, excepting a BO offer with one approval and several maybe approvals down the line presents an interesting challenge JL regarding when to except an offer and how do you place valuation on expected revenue or in the case of Merck it may not be just a revenue issue. It may be a save the company issue...